UTI AMC Q1 FY27 earnings call

UTI AMC reported a stable standalone core revenue of ₹308 crores for Q1 FY27, with a 1% QoQ increase. Standalone core EBITDA grew 20% QoQ to ₹171 crores, and standalone core PAT surged 72% QoQ to ₹119 crores. On a consolidated basis, core revenue was ₹379 crores, with consolidated EBITDA up 21% QoQ to ₹178 crores and consolidated PAT up 31% QoQ to ₹129 crores. These figures reflect a healthy growth trajectory across core businesses.

The mutual fund franchise strengthened, with Quarterly Average AUM (QAAUM) reaching ₹3,92,691 crores, contributing to a total group AUM of slightly over ₹20,00,000 crores. The industry's average AUM grew robustly by approximately 12.6% YoY to ₹84,18,486 crores in June 2026. Notably, equity assets (active and passive) now constitute 70% of UTI AMC's average mutual fund AUM, compared to the industry's 62:38 mix, indicating a focus on long-term wealth creation.

UTI AMC expanded its investor franchise by adding approximately 3.89 lakh folios, bringing the total live folio base to 1.42 crores, and 2.51 lakh new investors by PAN as of June 30, 2026. Gross SIP inflows for the quarter were ₹2,502 crores, and SIP AUM increased 8.05% YoY to ₹45,595 crores. Digital purchase transactions saw a significant 23.93% YoY increase, reaching 60.9 lakh in June 2026, underscoring growing adoption of digital platforms and engagement with investors across channels.

The alternatives business is gaining momentum, with total commitments reaching ₹3,843 crores, an increase from ₹2,679 crores in June 2025. UTI Pension Fund Limited recorded a 13% YoY growth in AUM, reaching approximately ₹4.31 lakh crores as of June 30, 2026. The company is actively expanding its presence in the MSME ecosystem and deepening rural outreach, reflecting its commitment to broadening pension access and supporting India's retirement savings ecosystem.

UTI International's AUM stood at USD 1.48 billion (₹14,027 crores) as of June 30, 2026. The international business has faced negative flows for the past two years, attributed to a lack of appetite for India and scheme underperformance, which management views as a cyclical issue. The strategy for international expansion post-2024 focuses on growth through alliances rather than building large, fixed cost bases upfront, aiming for a stable headcount after the US expansion.

The company's Mission 2031 strategy aims to transform UTI AMC into a larger, more competitive, technology-enabled, and investor-centric organization, targeting a 2x increase in current AUM. Key priorities include accelerating AUM growth, strengthening the SIP franchise, expanding distribution reach, deepening digital capabilities, and delivering better outcomes for investors. Management believes the company is well-positioned to participate meaningfully in the next phase of industry growth.

Employee costs for the standalone entity are guided to be around ₹95 crores per quarter for FY27, and approximately ₹130 crores per quarter for the consolidated entity. The increase in consolidated employee count to 1,512 from 1,435 in Q4 was primarily due to recruitments in the pension and alternatives subsidiaries. The sales reorganization efforts, including the VRS, have resulted in a leaner and more agile operating model, with a significant increase in Gen Z workforce representation.

Shareholders approved a final dividend of ₹40 per equity share, representing a 95% payout ratio. Despite sitting on cash equivalent to 40% of market capitalization, management stated that a buyback is not currently on the table. The company maintains optionality for future bolt-on acquisitions, not necessarily limited to AMC, but potentially in alternatives or international spaces, to leverage its cash reserves for strategic growth.